Evidence map›Paper›PMID 29740431›Full record

ArticleFrontiers in immunology2018

Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).

Morten Blaabjerg, Anne Louise Hemdrup, Lylia Drici, Klemens Ruprecht, Peter Garred, Romana Höftberger, Bjarne W Kristensen, Daniel Kondziella, Tobias Sejbaek, Soren W Hansen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Unusual CLIPPERS presentation with a predominant spinal cord involvement: case report and review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  2. Review
  3. Multimerin-1 and cancer: a review.Bioscience reports · 2022
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Morten BlaabjergDepartment of Neurology, Odense University Hospital, Odense, Denmark.
Anne Louise HemdrupDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Lylia DriciDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Klemens RuprechtClinical and Experimental Multiple Sclerosis Research Center, Charité - Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Peter GarredLaboratory of Molecular Medicine, Department of Clinical Immunology, Sect. 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Romana HöftbergerInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Bjarne W KristensenDepartment of Clinical Research, BRIDGE, University of Southern Denmark, Odense, Denmark.
Daniel KondziellaDepartment of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Tobias SejbaekDepartment of Neurology, Odense University Hospital, Odense, Denmark.
Soren W HansenInstitute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Helle H NielsenDepartment of Neurology, Odense University Hospital, Odense, Denmark.
Pia JensenDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Morten MeyerDepartment of Neurology, Zealand University Hospital, Roskilde, Denmark.
Friedemann PaulClinical and Experimental Multiple Sclerosis Research Center, Charité - Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Hans LassmannCenter for Brain Research, Medical University of Vienna, Vienna, Austria.
Martin R LarsenDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark.
Zsolt IllesDepartment of Neurology, Odense University Hospital, Odense, Denmark.
University of Southern Denmark · DKOdense University Hospital · DKMedical University of Vienna · ATBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DECopenhagen University Hospital · DKHumboldt-Universität zu Berlin · DERigshospitalet · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) is a rare syndrome with relapsing brainstem/cerebellar symptoms. To examine the pathogenic processes and investigate potential biomarkers, we analyzed combined materials of brain and cerebrospinal fluid (CSF) by comprehensive methodologies. Materials and methods: To identify major pathways of perivascular inflammation in CLIPPERS, we first compared the CSF proteome ( Results: Two hundred and seven proteins in the CSF discriminated CLIPPERS from AD. The complement cascade, immunoglobulins, and matrix proteins were among the most frequently represented pathways. Pathway analysis of upstream regulators suggested the importance of vascular cell adhesion protein 1 (VCAM1), IFN-γ, interleukin (IL)-1, and IL-10. Differential regulation of more than 10 complement proteins of the 3 complement pathways in the CSF pointed to the role of complement activation. IHC on brain samples confirmed the perivascular complement activation, i.e., deposition of C3bc, C3d, and the terminal C5b-9 complement complex that partially overlapped with accumulation of IgG in the vessel wall. Besides endothelial cell damage, reactivity to smooth muscle actin was lost in the walls of inflamed vessels, but the glia limitans was preserved. The semi-quantitative array indicated that increased level of IL-8/CXCL8 ( Conclusion: Complement activation, IgG deposition, and alterations of the extracellular matrix may contribute to inflammation in CLIPPERS. VCAM1, ICAM1, and IL-8 in the CSF may differentiate CLIPPERS from RMS.

Indexed as

AdultAgedAlzheimer DiseaseBiomarkersBrainCentral Nervous System DiseasesComplement System ProteinsFemaleHumansInflammationMaleMiddle AgedMultiple SclerosisProteinsProteomicsSyndromeBiomarkersComplement System ProteinsProteinscerebrospinal fluidCLIPPERScomplementICAM-1interleukin-8multiple sclerosisproteomicsVCAM-1

Identifiers

PMID29740431
PMCPMC5925867
OpenAlexW2800885607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.